CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Delamination of the Internal limiting membraneprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00419185
NCT00419185N/ACompleted
CompareCT.gov

Internal Limiting Membrane (ILM)- Peeling With Indocyanine Green or Trypan Blue in Macular Hole Surgery: A Prospective Randomized Trial

University of Luebeck·interventional·Posted Jan 8, 2007·Updated Jan 8, 2007

In Brief

A clinical study evaluating Delamination of the Internal limiting membrane for Idiopathic Macular Hole. Completed, across 1 site.

Detailed Summary

To evaluate the anatomical and visual outcomes after vitrectomy and internal limiting membrane (ILM) peeling with indocyanine green (ICG) or trypan blue (TB) for idiopathic macular hole repair in a prospective randomized trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Macular Hole
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 8, 2007
Enrollment StartApr 1, 2003
Study CompletionJan 1, 2005
TodayJul 2, 2026
Posted 19.5 years ago

Interventions

Delamination of the Internal limiting membraneprocedure